Resultado de búsqueda
28 de jun. de 2024 · FLEBOGAMMA DIF 100 mg/ml SOLUCION PARA PERFUSION, 1 vial de 50 ml. Laboratorio: INSTITUTO GRIFOLS S.A.. ATC: Sueros inmunes e inmunoglobulinas. Administración: Vía intravenosa. Principio activo: Inmunoglobulina humana normal.
Grifols es una compañía global líder en el sector de la salud. Nuestros innovadores medicamentos derivados del plasma, otros productos biofarmacéuticos y soluciones en medicina transfusional permiten mejorar la calidad de vida de millones de pacientes en todo el mundo.
21 de jun. de 2024 · Subcutaneous doses are based on the previously established intravenous IVIG dose. Initially, convert the dose by multiplying the current IVIG dose in grams by 1.37, then divide by the number of weeks between IV doses (e.g., if IVIG is administered every 3 weeks, divide by 3).
28 de jun. de 2024 · Grifols is a leading global healthcare company. Our trusted and innovative plasma-derived medicines, other biopharmaceuticals and solutions in transfusion medicine enable millions of patients around the world to lead more productive lives.
25 de jun. de 2024 · Flebogamma è un farmaco a base del principio attivo Immunoglobulina Umana Normale Per Uso Endovenoso, appartenente alla categoria degli Immunoglobuline umane normali e nello specifico Immunoglobuline, umane normali. E' commercializzato in Italia dall'azienda Grifols Italia S.p.A..
20 de jun. de 2024 · Basic Info. Drug Type. Blood components. Synonyms. Albuked, Albutein, Human Albumin Grifols. + [3] Target - Mechanism - Therapeutic Areas. Congenital Disorders Digestive System Disorders Endocrinology and Metabolic Disease + [4] Active Indication. Acute nephropathy Liver Cirrhosis Ovarian Hyperstimulation Syndrome + [7] Inactive Indication.
21 de jun. de 2024 · Immune Globulin (Human)(Grifols), Initially developed by Grifols Therapeutics, Inc., Now, its global highest R&D status is Approved, Therapeutic Areas: Immune System Diseases,Infectious Diseases,Nervous System Diseases, Active Indication: Acquired Immunodeficiency Syndrome,Agammaglobulinemia,Guillain-Barre Syndrome, Active Org.: Grifols ...
